Literature DB >> 22401862

Synthesis, crystal structures, in vitro biological evaluation of zinc(II) and bismuth(III) complexes of 2-acetylpyrazine N(4)-phenylthiosemicarbazone.

Ming-Xue Li1, Li-Zhi Zhang, Min Yang, Jing-Yang Niu, Jing Zhou.   

Abstract

Two metal complexes formulated as [Zn(L)(2)](2)·H(2)O (1) and [Bi(L)(NO(3))(2)(CH(3)OH)] (2), where HL=2-acetylpyrazine N(4)-phenylthiosemicarbazone, have been synthesized and characterized by elemental analysis, IR, MS, NMR and single-crystal X-ray diffraction studies. Biological studies, carried out in vitro against selected bacteria and the K562 leukemia cell lines, respectively, have shown that the free ligand and its two complexes may be endowed with important biological properties, especially HL with MIC=3.90 μg/mL against Pseudomonas aeruginosa, the zinc(II) complex 1 with IC(50)=1.0 μM against K562 leukemia cell lines, respectively. The compounds HL and 1 may exert their cytotoxicity activity via induced loss of mitochondria membrane potential (MMP).
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401862     DOI: 10.1016/j.bmcl.2012.02.024

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Design and synthesis of novel N()-substituted thiosemicarbazones bearing a pyrrole unit as potential anticancer agents.

Authors:  Taofeng Zhu; Shanshan Shen; Qin Lu; Xingpei Ye; Weiliang Ding; Ruhua Chen; Jing Xie; Wenjiao Zhu; Jun Xu; Lei Jia; Weina Wu; Tieliang Ma
Journal:  Oncol Lett       Date:  2017-04-05       Impact factor: 2.967

Review 2.  Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.

Authors:  Stephen Ahenkorah; Irwin Cassells; Christophe M Deroose; Thomas Cardinaels; Andrew R Burgoyne; Guy Bormans; Maarten Ooms; Frederik Cleeren
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

3.  Crystal structure of bis-(aceto-phenone 4-benzoyl-thio-semicarbazonato-κ(2) N (1),S)nickel(II).

Authors:  Faraidoon Karim Kadir; Mustaffa Shamsuddin; Mohd Mustaqim Rosli
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-04-29

4.  In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells.

Authors:  Rene Hernandez-Delgadillo; Claudia María García-Cuéllar; Yesennia Sánchez-Pérez; Nayely Pineda-Aguilar; Marco Antonio Martínez-Martínez; Eyra Elvyra Rangel-Padilla; Sergio Eduardo Nakagoshi-Cepeda; Juan Manuel Solís-Soto; Rosa Isela Sánchez-Nájera; María Argelia Akemi Nakagoshi-Cepeda; Shankararaman Chellam; Claudio Cabral-Romero
Journal:  Int J Nanomedicine       Date:  2018-10-05

Review 5.  Current and potential applications of bismuth-based drugs.

Authors:  Donal M Keogan; Darren M Griffith
Journal:  Molecules       Date:  2014-09-23       Impact factor: 4.411

6.  Novel Zinc(II) Complexes [Zn(atc-Et)₂] and [Zn(atc-Ph)₂]: In Vitro and in Vivo Antiproliferative Studies.

Authors:  Erica de O Lopes; Carolina G de Oliveira; Patricia B da Silva; Carlos E Eismann; Carlos A Suárez; Amauri A Menegário; Clarice Q F Leite; Victor M Deflon; Fernando R Pavan
Journal:  Int J Mol Sci       Date:  2016-05-21       Impact factor: 5.923

7.  Crystal structure, antibacterial and cytotoxic activities of a new complex of bismuth(III) with sulfapyridine.

Authors:  Ivana M Marzano; Marina S Franco; Priscila P Silva; Rodinei Augusti; Geandson C Santos; Nelson G Fernandes; Mônica Bucciarelli-Rodriguez; Edmar Chartone-Souza; Elene C Pereira-Maia
Journal:  Molecules       Date:  2013-01-24       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.